Project Grant R01MH137004

Award Date 9/1/24
Completion Date 3/31/29
Dollars Obligated $2.2M
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Providence, RI 02903, USA
Similar Awards
The National Institute of Mental Health (NIMH) awarded a $1,802,858 Project Grant (CFDA 93.242 Mental Health Research Grants) to the Scripps Research Institute in La Jolla, CA. The grant will fund research to map the functional impact of 72 high-confidence autism spectrum disorder and neurodevelopmental delay (ASD/NDD) risk genes using advanced in vivo genetic screening and whole-brain imaging technologies. This integrative approach aims to reveal how these genetic variants converge to produce...
The National Institute of Mental Health (NIMH) awarded a $422,280 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to the University of Colorado-Denver. The 2-year grant, running from April 1, 2025 to March 31, 2027, will support research to identify and interrogate novel intracellular proteins that underlie the distinct nanoscopic architecture of the synaptic adhesion molecules neurexin-1 and neurexin-3. Specifically, the research will use advanced imaging...
The National Institute of Mental Health (NIMH) awarded a $4,925,302 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to The Washington University to conduct systematic and scalable phenotyping of over 100 mouse mutants for neuropsychiatric disease genetics. The project, which runs from December 1, 2024 to November 30, 2029, will use behavioral analysis, anatomical mapping, and molecular assessments to investigate the impact of prioritized mutations associated with...
The National Institute of Mental Health (NIMH) awarded a $735,932 Project Grant (CFDA 93.242 - Mental Health Research Grants) to St. Jude Children's Research Hospital Inc. to elucidate the cellular mechanisms underlying positive symptoms, such as auditory hallucinations, in mouse models of two rare copy number variations (22q11.2 and 3q29 microdeletions) that confer a high risk of schizophrenia. The goal is to identify common disruptions to thalamocortical projections between the auditory...
The National Institute of Mental Health (NIMH) awarded a $439,804 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Creighton University. The grant supports a 5-year research project (11/15/2024 - 10/31/2029) to investigate the role of the lysine methyltransferase 5B (KMT5B) gene in regulating the expression of insulin-like growth factors (IGF1 and IGF2) and their impact on brain development and autism spectrum disorder. The research aims to specify KMT5B's role in...
This Project Grant award of $742,484 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program will fund research to characterize a genetic mouse model and delineate its function in the brain. The award to the University of Alabama at Birmingham will span 5 years from January 2025 to October 2029. The research aims to identify novel downstream targets in the mammalian brain, elucidate behavioral outcome measures, and generate new hypotheses...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $2,181,744.00 to The Trustees of the University of Pennsylvania to conduct research on the molecular and circuit mechanisms by which neurexin1 (NRXN1) gene mutations contribute to goal-directed dysfunction across neuropsychiatric disorders. The 5-year project, starting on September 25, 2024 and ending on May 31, 2029, will employ...
This $853,953 Project Grant, awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program, supports research to investigate the neurocomputational mechanisms underlying belief updating. The project aims to extend a recently developed computational framework for belief updating, based on contextual inference, across multiple neuroscience domains. Key objectives include: 1) Measuring the generalizability of the contextual inference model...
The National Institute of Mental Health (NIMH) awarded a $1,380,070 Project Grant (CFDA 93.242 - Mental Health Research Grants) to Duke University to explore the cellular properties and circuit functional roles of human cortical interneurons. This research aims to generate a multimodal phenotypic catalog of human interneurons and characterize their functional organization in neural circuits. The project will utilize live brain specimens collected from neurosurgical procedures and a novel genetic...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), is providing $610,784 to Emory University to conduct comprehensive research on the role of neuroinflammation in 22q11.2 Deletion Syndrome (22QDS). The research aims to assess the impact of 22QDS on microglial function using patient-derived induced pluripotent stem cell (iPSC) models, determine the molecular and cellular effects of 22q11.2 deletions on...

The National Institute of Mental Health (NIMH) awarded a $2,247,313 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Brown University. The 5-year grant, awarded on September 1, 2024, will support research to define defective neurodevelopmental mechanisms caused by 17q12 copy number variants (CNVs), particularly 17q12 deletions, which are a high-risk factor for autism and related neurodevelopmental disorders. The research will utilize unique experimental resources including a 17q12 deletion mouse model and patient-derived induced pluripotent stem cells to investigate transcriptional mechanisms, molecular pathways, and postnatal neurodevelopmental and behavioral abnormalities. This integrated, cross-species approach aims to advance understanding of the diversity of phenotypes and potential treatment strategies for neuropsychiatric disorders associated with 17q12 CNVs.

Generated 8/5/25, 5:14 AM